From The Editor | July 30, 2013

How Is Risk Changing The Relationship Between Sponsors And CROs?

By Ed Miseta, Chief Editor, Clinical Leader

Ed Miseta

There are many risks faced by companies operating in the clinical trial space. Jamie Macdonald, CEO of global CRO INC Research, has been a keen observer of risk in the industry with deep experience managing through changing approaches in clinical development. He has taken time to speak with customers, colleagues, and competitors in the CRO space about their business relationships. He believes changes currently occurring in risk management are driving many sponsors and CROs to reevaluate the nature of their relationships, and in many cases, changing those relationships for the better.

access the From The Editor!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma